Latest News and Press Releases

New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Microtome Market to Exhibit Growth at a CAGR of ~6% by 2032 | DelveInsight  The rising demand for microtomes is largely driven by the growing...

New York, USA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight  The growing demand for immune checkpoint inhibitors is...

New York, USA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of...

LOS GATOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent...

New York, USA, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Global Artificial Sweeteners Market to Observe Growth at a CAGR of ~4% by 2030 | DelveInsight The growing demand for artificial sweeteners is mainly...

New York, USA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Global Clinical Laboratory Service Market to Cross ~USD 400 Billion Mark by 2030 | DelveInsight The increasing demand for clinical laboratory...

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024 –...

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024...

New York, USA, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Global Asthma Treatment Market to Cross ~USD 32 Billion by 2030 | DelveInsight The increasing demand for asthma treatment is largely driven by...

New York, USA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- VEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight VEGFR2 (vascular endothelial growth factor receptor...